scispace - formally typeset
Q

Qinqin Xu

Researcher at LSU Health Sciences Center Shreveport

Publications -  15
Citations -  256

Qinqin Xu is an academic researcher from LSU Health Sciences Center Shreveport. The author has contributed to research in topics: Apoptosis & Programmed cell death. The author has an hindex of 6, co-authored 13 publications receiving 199 citations. Previous affiliations of Qinqin Xu include Zhejiang University & Mayo Clinic.

Papers
More filters
Journal ArticleDOI

Arginine and glutamate-rich 1 (ARGLU1) interacts with mediator subunit 1 (MED1) and is required for estrogen receptor-mediated gene transcription and breast cancer cell growth.

TL;DR: ARGLU1 is established as a new MED1-interacting protein required for estrogen-dependent gene transcription and breast cancer cell growth, as well as anchorage-dependent and -independent colony formation of breast cancer cells.
Journal ArticleDOI

Kinetic cellular phenotypic profiling: prediction, identification, and analysis of bioactive natural products.

TL;DR: A novel cell-based phenotypic profiling strategy that uses electronic impedance readouts for real-time monitoring of cellular responses to traditional Chinese medicines (TCMs) and suggests that using TCRP as an alternative to existing spectroscopic techniques can allow us to analyze natural products in a more convenient and physiologically relevant manner.
Journal ArticleDOI

SHP2 Positively Regulates TGFβ1-induced Epithelial-Mesenchymal Transition Modulated by Its Novel Interacting Protein Hook1

TL;DR: The data showed that the protein-tyrosine phosphatase SHP2 was involved in the process of EMT and Hook1 repressed EMT by regulating the activation ofSHP2, which suggested that Hook1 was an endogenous negative regulator of SHp2 phosphat enzyme activity.
Journal ArticleDOI

Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival.

TL;DR: The notion that the cereblon binding partner AGO2 plays an important role in regulating MM cell growth and survival and AGO 2 could be considered as a novel drug target for overcoming IMiD resistance in MM cells is supported.
Journal ArticleDOI

Unusual Spirodecane Sesquiterpenes and a Fumagillol Analogue from Cordyceps ophioglossoides

TL;DR: In this paper, the authors investigated the cultured mycelia of Cordyceps ophioglossoides and found three unusual spiro[4.5]decane sesquiterpenes, cordycepol A (1), cordycopepla B (2), and cordycerol C (3), and a new fumagillol analogue cordycol (4).